Brendan Hannah - 04 Jun 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role: CHIEF BUSINESS OFFICER AND COO
Signature: /s/ Brendan Hannah
Issuer symbol: QNCX
Transactions as of: 04 Jun 2024
Net transactions value: +$30,834
Form type: 4
Filing time: 05 Jun 2024, 14:37:39 UTC
Previous filing: 02 Feb 2024
Next filing: 21 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QNCX	Common Stock	Options Exercise	$30,834	+56,061	+28%	$0.5500	257,616	04 Jun 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Employee Stock Option (right to buy)	Options Exercise	$0	-56,061	-54%	$0.000000	47,439	04 Jun 2024	Common Stock	56,061	$0.5500	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.